Azilsartan ameliorates ox-LDL-induced endothelial dysfunction via promoting the expression of KLF2

Background: Oxidized LDL(Ox-LDL) mediated endothelial dysfunction is involved in the pathogenesis of various cardiovascular diseases, including atherosclerosis. Azilsartan is a potent agent for the treatment of hypertension as the antagonist of the angiotensin II receptor. This study will investigat...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Wenfeng, Wang, Chenggao, Zhang, Dandan, Zeng, Kanghua, Xiao, Shihui, Chen, Feng, Luo, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8148451/
https://www.ncbi.nlm.nih.gov/pubmed/33946046
http://dx.doi.org/10.18632/aging.202973

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8148451/
https://www.ncbi.nlm.nih.gov/pubmed/33946046
http://dx.doi.org/10.18632/aging.202973

Ejemplares similares